Andrew S. Boyer, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 125,422 shares at $7.85 ($983K) on 2024-08-15, disclosed to the SEC on 2024-08-16.
Open-market sale of $983k AMRX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.81 | 22,486 | $176K | 17.9% |
| 2 | $7.81 | 22,486 | $176K | 17.9% |
| 3 | $7.85 | 40,225 | $316K | 32.1% |
| 4 | $7.85 | 40,225 | $316K | 32.1% |
| Total | $7.84 avg | 125,422 | $983K | 100% |
| Filing → |
| AMRX | SELL | 2025-03-07 | $1.1M | — | Filing → |
| AMRX | SELL | 2023-08-15 | $242K | — | Filing → |
| AMRX | BUY | 2019-08-07 | $385K | — | Filing → |